Suppr超能文献

替马沙星及其他氟喹诺酮类药物对典型和非典型社区获得性呼吸道病原体的活性。

Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.

作者信息

Hardy D J

机构信息

Department of Microbiology and Immunology, University of Rochester Medical Center, New York 14642-8710.

出版信息

Am J Med. 1991 Dec 30;91(6A):12S-14S. doi: 10.1016/0002-9343(91)90302-e.

Abstract

The microbiologic activities of temafloxacin, ciprofloxacin, and ofloxacin against community-acquired respiratory tract pathogens are reviewed. The 90% minimal inhibitory concentrations (MIC90s) of these fluoroquinolones for gram-negative pathogens were generally comparable, that is, less than 0.06 micrograms/mL. Overall, the agents were less active against gram-positive pathogens, although temafloxacin was two- to fourfold more active than the other agents against staphylococci and streptococci. For strains of Mycoplasma pneumoniae and Chlamydia pneumoniae, temafloxacin was generally inhibitory at concentrations of 0.5-2 micrograms/mL. This microbiologic activity, combined with its pharmacokinetic profile, should make temafloxacin a useful antimicrobial agent for treating community-acquired respiratory tract infections.

摘要

本文综述了替马沙星、环丙沙星和氧氟沙星对社区获得性呼吸道病原体的微生物学活性。这些氟喹诺酮类药物对革兰氏阴性病原体的90%最小抑菌浓度(MIC90)通常相当,即低于0.06微克/毫升。总体而言,这些药物对革兰氏阳性病原体的活性较低,尽管替马沙星对葡萄球菌和链球菌的活性比其他药物高两到四倍。对于肺炎支原体和肺炎衣原体菌株,替马沙星通常在浓度为0.5 - 2微克/毫升时具有抑制作用。这种微生物学活性及其药代动力学特征,应使替马沙星成为治疗社区获得性呼吸道感染的有用抗菌药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验